Skip to main content

Table 2 The performance of OncoUrine for diagnosis in bladder cancer (bladder cancer diagnosis)

From: A urinary assay for mutation and methylation biomarkers in the diagnosis and recurrence prediction of non-muscle invasive bladder cancer patients

OncoUrine

Pathology

Positive

Negative

Total

Positive

8

3

11

Negative

2

34

36

Total

10

37

47

 

n/N

% (95% CI)

Sensitivity

8/10

80.0 (44.2–96.5)

Specificity

34/37

91.9 (77.0–97.9)

PPV

8/11

72.7 (39.3–92.7)

NPV

34/36

94.4 (80.0–99.0)

Kappa value

 

69.4 (44.4–94.3)

Spared Cystoscopy

34/47

72.3

Back to article page

BMC Medicine

ISSN: 1741-7015

Contact us